07.08.2019 14:34:51
|
ANI Pharmaceuticals, Inc. Q2 adjusted earnings Beat Estimates
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its second quarter that climbed from last year.
The company's earnings came in at $6.59 million, or $0.53 per share. This compares with $2.78 million, or $0.23 per share, in last year's second quarter.
Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $17.28 million or $1.44 per share for the period.
Analysts had expected the company to earn $1.28 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 15.0% to $54.36 million from $47.27 million last year.
ANI Pharmaceuticals, Inc. earnings at a glance:
-Earnings (Q2): $17.28 Mln. vs. $13.374 Mln. last year. -EPS (Q2): $1.44 vs. $1.13 last year. -Analysts Estimate: $1.28 -Revenue (Q2): $54.36 Mln vs. $47.27 Mln last year.
-Guidance: Full year EPS guidance: $5.57 to $6.21 Full year revenue guidance: $220 to $226 Mln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
07.11.24 |
Ausblick: Biosante Pharmaceuticals verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
05.08.24 |
Ausblick: Biosante Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |